Keymed Biosciences

Keymed Biosciences develops innovative monoclonal antibody drugs and other therapeutic protein drugs for major diseases.

Operating in biotechnology, health care, life science, therapeutics based in Asia-Pacific (APAC), Keymed Biosciences was founded in 2016.

Its activity falls under biotechnology, health care, life science, therapeutics; the profile below is assembled from public directory data.

Its base of operations is Asia-Pacific (APAC).

It is recorded at the Private company stage.

Recorded headcount: c_00011_00050 employees.

Sector	Biotechnology, Health Care, Life Science, Therapeutics
Headquarters	Asia-Pacific (APAC)
Founded	2016
Employees	c_00011_00050
Stage	Private company

Website: en.keymedbio.com

Contact details and direct channels are available to signed-in members.
Create a free account

Browse related